Anti-TNF-alpha drugs - moving into the mainstream?
Published on 12/24/09 by Tina Ding, Chris Deighton
Anti-TNF drugs are a major treatment advance in the management of inflammatory disorders such as rheumatoid arthritis, and are typically considered following unsuccessful treatment with conventional disease-modifying antirheumatic drugs (DMARDs). Drs Chris Deighton and Tina Ding review the available anti-TNF-alpha drugs, and consider their future place in therapy. Copyright © 2009 John Wiley & Sons, Ltd.
Read full article on Wiley Interscience
Other Journals
lm journal ad block

